Celcuity CELC
NASDAQ CELC
$72.10 -3.03 (-4.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celcuity (CELC) Other Accumulated Expenses (2018 - 2026)

Updated

Celcuity (CELC) recorded Other Accumulated Expenses of $20.58 million in Q2 2026.

Analysis

Celcuity (CELC) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Celcuity reported Other Accumulated Expenses of $15.87 million, up 189.7% from FY2024.

  • Annual Other Accumulated Expenses has increased for four straight years, with a four-year compound annual growth rate of 145.3% (FY2021 to FY2025).
  • Across earlier years, Other Accumulated Expenses came in at $5.48 million in FY2024 (+210.6%), $1.76 million in FY2023 (+89.8%), $929,216 in FY2022 (+111.9%) and $438,477 in FY2021.
  • The Q2 2026 figure is the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Celcuity 3.68 Bn 3.68 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.58 Mn
Dec 31, 2025 15.87 Mn
Dec 31, 2024 5.48 Mn
Dec 31, 2023 1.76 Mn
Dec 31, 2022 929,216.00
Dec 31, 2021 438,477.00
Dec 31, 2019 112,746.00
Dec 31, 2018 52,347.00
API Access

Celcuity Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CELC&period=max&api_key=YOUR_API_KEY